INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 273 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,130 | -9.0% | 501,625 | +10.6% | 0.41% | -1.2% |
Q2 2023 | $28,708 | +3.7% | 453,375 | -11.3% | 0.41% | +2.0% |
Q1 2023 | $27,675 | -26.1% | 511,075 | -27.8% | 0.40% | -24.2% |
Q4 2022 | $37,467 | -99.9% | 708,000 | -20.0% | 0.53% | -7.0% |
Q3 2022 | $41,203,000 | -9.9% | 885,510 | +10.6% | 0.57% | -10.0% |
Q2 2022 | $45,712,000 | -14.8% | 800,838 | -8.7% | 0.64% | +5.8% |
Q1 2022 | $53,665,000 | -23.7% | 877,028 | -34.7% | 0.60% | -3.4% |
Q4 2021 | $70,343,000 | +9.8% | 1,343,965 | -21.8% | 0.62% | +11.4% |
Q3 2021 | $64,072,000 | +36.1% | 1,718,665 | +49.0% | 0.56% | +45.2% |
Q2 2021 | $47,081,000 | +13.1% | 1,153,380 | -6.0% | 0.38% | +7.8% |
Q1 2021 | $41,642,000 | +47.3% | 1,227,280 | +38.0% | 0.36% | +55.2% |
Q4 2020 | $28,277,000 | +22.1% | 889,200 | -1.5% | 0.23% | +6.0% |
Q3 2020 | $23,158,000 | -0.0% | 902,500 | -41.2% | 0.22% | +40.0% |
Q4 2016 | $23,162,000 | -13.5% | 1,534,938 | -12.6% | 0.16% | -10.4% |
Q3 2016 | $26,770,000 | -57.4% | 1,756,575 | +8.4% | 0.17% | -58.4% |
Q2 2016 | $62,884,000 | +48.4% | 1,619,875 | +6.3% | 0.42% | +50.2% |
Q1 2016 | $42,378,000 | -40.2% | 1,524,375 | +15.6% | 0.28% | -38.0% |
Q4 2015 | $70,918,000 | +61.0% | 1,318,420 | +19.9% | 0.45% | +62.0% |
Q3 2015 | $44,044,000 | – | 1,100,000 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DCF Advisers, LLC | 359,000 | $18,790,000 | 7.62% |
Velan Capital Investment Management LP | 150,000 | $7,851,000 | 6.09% |
SILVERARC CAPITAL MANAGEMENT, LLC | 195,000 | $10,206,000 | 4.14% |
Vantage Consulting Group Inc | 226,670 | $11,864,000 | 3.19% |
Vahanian & Associates Financial Planning Inc. | 71,742 | $3,755,000 | 3.03% |
Nicholas Investment Partners, LP | 652,886 | $34,172,000 | 2.16% |
COOPER/HAIMS ADVISORS, LLC | 61,116 | $3,199,000 | 1.97% |
Bellevue Group AG | 3,628,919 | $189,938,000 | 1.96% |
WASATCH ADVISORS LP | 8,235,171 | $431,029,000 | 1.76% |
Quantum Private Wealth, LLC | 77,622 | $4,062,000 | 1.54% |